DrugPatentWatch Database Preview
Litigation Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)
» See Plans and Pricing
INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)
| Docket | Start Trial | Date Filed | 2014-11-07 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1 Antitrust Litigation | Assigned To | Madeline Cox Arleo |
| Jury Demand | Plaintiff | Referred To | Michael A. Hammer |
| Patents | 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 7,119,106; 7,465,800; 8,288,415; 8,315,886; 8,404,717 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-11-07 | 1 | . Celgene’s patents on the procedures for safe distribution are the 6,045,501 patent, the 6,315,720… Herein 6,045,501 ‘501 patent August 28, 1998 April…manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…6,315,720 patent, the 6,561,976 patent, the 6,561,977 patent and the 6,755,784 patent (the “Distribution Method…information describing the patent as a “drug product patent” only if the patent claimed the drug product | External link to document | |
| 2015-02-03 | 20 | Brief | Complaint, IUB only explicitly labels U.S. Patent Nos. 6,045,501, 6,315,720, 6,651,976, 6,561,977, and …three dozen patents, other than the six Distribution Method patents, in its broad patent portfolio covering… Method Patents (Compl. ¶¶ 123-210) – the patent examiner would not have issued the patent claim. See…liable for asserting its patents to preclude generic competition unless the patents in … other patents covering Revlimid and Thalomid were the subject of either fraud on the patent office | External link to document |
| 2015-10-29 | 68 | Revlimid: Patent No. 6,045,501 (“the ’501 Patent”); Patent No. 6,315,720 (“the ’720 Patent”); Patent No. …’976 Patent”); Patent No. 6,561,977 (“the ’977 Patent”); Patent No. 6,755,784 (“the ’784 Patent”); and…230 Patent”), Patent No. 6,555,554 (“the ’554 Patent”), Patent No. 7,119,106 (“the ’106 Patent”), and…obtained: the ’720 Patent in 2001; the ’976 Patent and ’977 Patent in 2003; and the ’784 Patent in 2004. (Id…five Distribution Patents, along with Patent No. 5,635,517 (“the ’517 Patent”), Patent No. 6,281,230 ( | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
